AGP Executive Report
Last update: 5 hours agoEbola Preparedness: With the 2026 World Cup underway, U.S. infectious-disease experts say the chance of an Ebola case arriving is low but not zero—and hospitals in host cities are ready after major lessons from 2014. Alzheimer’s Pipeline: FDA granted Fast Track status to Regeneration Biomedical’s direct-to-brain autologous stem cell therapy for Alzheimer’s after encouraging early safety and biomarker signals. Medicaid Expansion (Territories): Guam plans a new Medicaid HCBS waiver to fund home and community services, aiming to reduce avoidable hospitalizations and boost independence. Infectious Threats to Food Supply: USDA is preparing a major response to the New World screwworm after confirmed cases in Texas and New Mexico, with sterile-fly releases and pet-risk guidance. Rural/State Health Access: Wyoming’s older adults are missing out on an estimated $58B in key benefits, with low enrollment in Medicare Savings, SNAP, and SSI. Vision Manufacturing: Johnson & Johnson is investing $1B in Jacksonville, expanding U.S. production and distribution for ACUVUE contact lenses. Maternal Health Shortage: The U.S. faces a shortage of Bicillin L-A, the first-line treatment for pregnant women with syphilis, with supplies not expected to normalize until late 2027. Policy & Coverage Watch: CMS and other regulators continue shaping care pathways, while new device-market growth reports highlight momentum in neurostimulation, neurovascular tools, and medical sensors.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
